CAITLIN SULLIVAN
NEW ORLEANS, LA NPI 1912401696
Browse related groups: LA PFIZER INC. All categories
General Payments — all program years on this page
$182.39
- Category: General Payments
- Program years: PY2023–2024
- Record count: 9
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $167.76 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.76 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $28.26 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.66 | 1 |
| Lilly USA, LLC | $21.87 | 1 |
| Genentech USA, Inc. | $20.56 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.12 | 1 |
| SERVIER PHARMACEUTICALS LLC | $19.43 | 1 |
| Myriad Genetic Laboratories, Inc. | $19.26 | 1 |
| Novo Nordisk AS | $15.60 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1108581953 | Novo Nordisk Inc | $15.60 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110507834 | Alexion Pharmaceuticals, Inc. | $22.66 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1130878890 | PFIZER INC. | $28.26 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1132983605 | Genentech USA, Inc. | $20.56 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136079329 | Lilly USA, LLC | $21.87 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137683814 | Takeda Pharmaceuticals U.S.A., Inc. | $20.12 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1147258558 | SERVIER PHARMACEUTICALS LLC | $19.43 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1152540913 | Myriad Genetic Laboratories, Inc. | $19.26 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.